arrow
K

Kelly D. Flemming

university zurich hospital
H指数:42
被引数:6,165

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Functional and Patient-Reported Outcomes in the Atorvastatin versus Placebo Trial of Hemorrhagic Cerebral Cavernous Malformations: An Exploratory Study

阿托伐他汀与安慰剂治疗出血性脑海绵状血管瘤的疗效和患者报告结局:一项探索性研究

2026-01-010
PRE
Identifying features of prior hemorrhage in cerebral cavernous malformations on quantitative susceptibility maps: a machine learning pilot study

识别脑海绵状血管畸形定量磁化率图上前次出血的特征:一项机器学习试点研究

2025-12-010
PRE
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling
STROKE
IF8.9
2024-01-011
PRE
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome
STROKE
IF8.9
2024-01-014
PRE
Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project
STROKE
IF8.9
2021-12-018
OA
A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH)
2021-03-0120
OA
Baseline Characteristics of Patients With Cerebral Cavernous Angiomas With Symptomatic Hemorrhage in a Multisite Trial Readiness Study.
STROKE
IF8.9
2021-03-011
PRE